-
1دورية أكاديمية
المؤلفون: Huang, Liling, Lou, Ning, Xie, Tongji, Tang, Le, Han, Xiaohong, Shi, Yuankai
المصدر: Cancer Immunology, Immunotherapy; Oct2023, Vol. 72 Issue 10, p3259-3277, 19p
مصطلحات موضوعية: RNA sequencing, MEDICAL sciences, IMMUNE checkpoint inhibitors, DISEASE risk factors, KILLER cells, PROGRAMMED cell death 1 receptors
-
2دورية أكاديمية
المؤلفون: Feng, Yu, Tao, Yunxia, Chen, Haizhu, Zhou, Yu, Tang, Le, Liu, Chenwei, Hu, Xingsheng, Shi, Yuankai
المصدر: Thoracic Cancer; Sep2023, Vol. 14 Issue 25, p2536-2547, 12p
مصطلحات موضوعية: LUNG cancer, IMMUNE checkpoint inhibitors, META-analysis, SYSTEMATIC reviews, TREATMENT effectiveness, DESCRIPTIVE statistics, RESEARCH funding, PATIENT safety, PHARMACODYNAMICS
-
3دورية أكاديمية
المؤلفون: Feng, Yu1 (AUTHOR), Tang, Le1 (AUTHOR), Wang, Hongyu1 (AUTHOR), Liu, Yutao1 (AUTHOR), Yang, Sheng1 (AUTHOR), Lin, Lin1 (AUTHOR), Hu, Xingsheng1 (AUTHOR) huxingsheng66@163.com, Shi, Yuankai1 (AUTHOR) syuankai@cicams.ac.cn
المصدر: Cancer Immunology, Immunotherapy. Feb2023, Vol. 72 Issue 2, p449-459. 11p.
مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *IPILIMUMAB, *NEOVASCULARIZATION inhibitors, *ADENOCARCINOMA, *ADVERSE health care events, *PROGNOSIS
-
4دورية أكاديمية
المؤلفون: Chen, Haizhu, Feng, Yu, Zhou, Yu, Tao, Yunxia, Tang, Le, Shi, Yuankai
المصدر: Cancer Immunology, Immunotherapy; Dec2022, Vol. 71 Issue 12, p3071-3085, 15p
مصطلحات موضوعية: NON-small-cell lung carcinoma, IMMUNE checkpoint inhibitors, IPILIMUMAB, PROGRAMMED death-ligand 1